1) WHO:Global tuberculosis control;WHO report 2011. WHO/HTM/TB/2011.16
2) 厚生労働省:結核登録者情報システム年報報告2010.結核予防会,2011
3) 結核療法研究協議会細菌科会:結核菌の薬剤感受性状況に関する調査(第14回調査).平成22年療研研究報告書,pp11-26, 2011
4) Geiter L(ed):Committee on the Elimination of Tuberculosis in the United States. Division of Health Promotion and Disease Prevention. Institute of Medicine;Ending Neglect. Consensus Statement of the Public Health Tuberculosis Guidelines Panel. National Academy Press, Washington, D.C., 2000
5) EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region:Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2006. Institut de veille sanitaire, Saint-Maurice, France, March 2008
6) Reported Tuberculosis in the United States, 2010. Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination, 2011
7) Schwartzman K, et al:Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med 353:1008-1020, 2005
8) Klinkenberg E, et al:Migrant tuberculosis screening in the EU/EEA;yield, coverage and limitations. Eur Respir J 34(5):1180, 2009
9) United Nations:Demographic Yearbook, 2009
10) 結核研究所疫学情報センター:結核年報2008;Series 2 外国人結核.結核84:743-746, 2009
11) 厚生労働省:結核に関する特定感染症予防指針,2011
12) 文部科学省:学校における結核対策マニュアル,2012
13) 結核予防会結核電話相談ホームページ(www.jata.org/headquarters/index9.html)